​

Jazz Pharmaceuticals Ownership | Who Owns Jazz Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Jazz Pharmaceuticals Ownership Summary

Jazz Pharmaceuticals is owned by 95.98% institutional investors, 3.07% insiders, and 0.96% retail investors. Blackrock is the largest institutional shareholder, holding 9.83% of JAZZ shares. Pacer US Cash Cows 100 ETF is the top mutual fund, with 3.55% of its assets in Jazz Pharmaceuticals shares.

JAZZ Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockJazz Pharmaceuticals95.98%3.07%0.96%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%
IdeaCannabis Stocks List16.95%11.09%71.96%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock6.15M9.83%$655.94M
Vanguard group5.91M9.65%$778.54M
Blackrock funding, inc. /de5.56M9.08%$732.72M
Dimensional fund advisors lp2.84M4.64%$373.86M
Capital world investors2.55M4.17%$336.73M
Lsv asset management2.51M4.10%$331.06M
State street1.87M3.05%$246.19M
Jpmorgan chase1.87M3.05%$246.09M
Ameriprise financial1.85M3.02%$243.49B
Ecor1 capital1.71M2.79%$224.91M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ecor1 capital1.71M10.79%$224.91M
Krensavage asset management167.82K9.42%$22.12M
Saturn v capital management300.61K8.69%$39.62M
Estuary capital management lp363.15K8.50%$47.86M
Superstring capital management lp40.89K5.31%$5.39M
Gmt capital792.80K4.74%$104.49M
Polaris capital management513.47K4.45%$67.67M
Sofinnova investments588.83K4.24%$77.61M
Acuta capital partners25.11K3.42%$3.31M
Vestal point capital, lp500.00K2.98%$65.90M

Top Buyers

HolderShares% AssetsChange
Schonfeld strategic advisors436.44K0.33%373.38K
Dimensional fund advisors lp2.84M0.08%298.81K
Woodline partners lp264.97K0.16%232.28K
Jane street group273.31K0.01%230.96K
Wedge capital management l l p/nc211.19K0.47%211.19K

Top Sellers

HolderShares% AssetsChange
Baupost group llc/ma---1.27M
Camber capital management lp---1.15M
Blackrock6.15M0.01%-924.16K
Vestal point capital, lp500.00K2.98%-700.00K
Rubric capital management lp---616.62K

New Positions

HolderShares% AssetsChangeValue
Walleye capital82.79K0.04%82.79K$10.91M
Centre asset management75.80K2.14%75.80K$9.34M
Abrdn65.47K0.01%65.47K$8.63M
Axa investment managers59.87K0.02%59.87K$7.89M
Stempoint capital lp39.07K1.03%39.07K$5.15M

Sold Out

HolderChange
Whittier trust co of nevada-1.00
Harbor investment advisory-1.00
Center for financial planning-1.00
Psi advisors-1.00
Kiker wealth management-1.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025488-2.59%58,731,791-0.37%951.03%208-15.10%1876.86%
Jun 30, 2025498-10.75%61,731,8556.44%1001.12%243-23.10%17512.18%
Mar 31, 20255528.02%58,706,955-0.60%961.04%31219.54%155-7.74%
Dec 31, 2024468-2.50%56,158,556-2.64%911.04%238-155-1.27%
Sep 30, 20244732.83%57,472,0080.00%931.12%2357.31%155-6.06%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Pacer US Cash Cows 100 ETF2.16M3.55%3.19K
iShares Core S&P Mid-Cap ETF2.01M3.31%-
American Funds Fundamental Invs A2.00M3.31%105.19K
Capital Group Fundamental Invtrs Comp2.00M3.31%105.19K
Vanguard Total Stock Mkt Idx Inv1.85M3.04%-45.46K
Vanguard US Total Market Shares ETF1.84M3.03%-44.10K
FullerThaler Behavioral Sm-Cp Eq R61.55M2.56%283.68K
FullerThaler Behavioral Small-Cap Equity1.55M2.56%283.68K
Vanguard Small Cap Index1.42M2.35%-8.43K
JPMorgan Mid Cap Value L936.84K1.54%18.14K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 05, 2025Carr Patricia SVP, Chief Accounting OfficerSell$770.41K
Dec 05, 2025Carr Patricia SVP, Chief Accounting OfficerSell$27.38K
Nov 26, 2025COZADD BRUCE C-Sell$91.15K
Nov 26, 2025COZADD BRUCE C-Sell$5.43M
Nov 26, 2025COZADD BRUCE C-Sell$1.50M

Insider Transactions Trends

DateBuySell
2025 Q4-15
2025 Q3-5
2025 Q245
2025 Q1-10
2024 Q4-4

JAZZ Ownership FAQ

Who Owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals shareholders are primarily institutional investors at 95.98%, followed by 3.07% insiders and 0.95% retail investors. The average institutional ownership in Jazz Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Jazz Pharmaceuticals exceeds.

Who owns the most shares of Jazz Pharmaceuticals?

Jazz Pharmaceuticals’s largest shareholders are Blackrock (6.15M shares, 9.83%), Vanguard group (5.91M shares, 9.65%), and Blackrock funding, inc. /de (5.56M shares, 9.08%). Together, they hold 28.56% of Jazz Pharmaceuticals’s total shares outstanding.

Does Blackrock own Jazz Pharmaceuticals?

Yes, BlackRock owns 9.83% of Jazz Pharmaceuticals, totaling 6.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 655.94M$. In the last quarter, BlackRock decreased its holdings by -924K shares, a -13.07% change.

Who is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ecor1 capital is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 10.79% of its assets in 1.71M Jazz Pharmaceuticals shares, valued at 224.91M$.

Who is the top mutual fund holder of Jazz Pharmaceuticals shares?

Pacer US Cash Cows 100 ETF is the top mutual fund holder of Jazz Pharmaceuticals shares, with 3.55% of its total shares outstanding invested in 2.16M Jazz Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools